Results 221 to 230 of about 102,224 (277)
Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma
Huan Liu, Zhiqiang Liu, Pei Lin
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Thymidine phosphorylase expression in endometrial carcinomas
Clinical & Experimental Metastasis, 1999Thymidine phosphorylase (TP) is a potent angiogenic molecule shown to induce endothelial cell migration and proliferation. We investigated the expression of TP in a series of 156 endometrial carcinomas, using immunohistochemical methods. Histopathological parameters of known prognostic significance and the molecular factors of p53, bcl-2 and ...
E, Sivridis +5 more
openaire +2 more sources
Thymidine Phosphorylase Expression in Gallbladder Adenocarcinomas
International Journal of Surgical Pathology, 2002The expression of thymidine phosphorylase (TP), a potent chemotactic factor for enothelial cells, was studied in 60 adenocarcinomas of the gallbladder, by use of imunohistochemical techniques. Results on patterns of TP expression were correlated with angiogenesis (anti-CD31), histopathological variables, and patient survival.
Alexandra, Giatromanolaki +6 more
openaire +2 more sources
Nucleosides, Nucleotides and Nucleic Acids, 2014
TAS-102 (trifluorothymidine [TFT] and thymidine phosphorylase inhibitor [TPI] in a molar ratio of 1:0.5) has activity in 5-fluorouracil resistant colon cancer. TPI is added to increase TFT's bioavailability. TFT has a dual mechanism of action by inhibiting thymidylate synthase and by its incorporation into DNA.
El-Naggar, M. +4 more
openaire +4 more sources
TAS-102 (trifluorothymidine [TFT] and thymidine phosphorylase inhibitor [TPI] in a molar ratio of 1:0.5) has activity in 5-fluorouracil resistant colon cancer. TPI is added to increase TFT's bioavailability. TFT has a dual mechanism of action by inhibiting thymidylate synthase and by its incorporation into DNA.
El-Naggar, M. +4 more
openaire +4 more sources
Thymidine phosphorylase inhibits apoptosis induced by cisplatin
Biochemical and Biophysical Research Communications, 2003An angiogenic factor, platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP), stimulates the chemotaxis of endothelial cells and confers resistance to apoptosis induced by hypoxia. 2-Deoxy-D-ribose, a degradation product of thymidine generated by TP, partially prevents hypoxia-induced apoptosis.
Ryuji, Ikeda +15 more
openaire +2 more sources
Purification of thymidine phosphorylase from human amniochorion
Biochimica et Biophysica Acta (BBA) - Enzymology, 1978Thymidine phosphorylase (thymidine : orthophosphate deoxyribosyltransferase, EC 2.4.2.4) has been purified 1500-fold from extracts of human amniochorion. The purified enzyme catalyzes the phosphorolysis of deoxythymidine and to a lesser extent deoxyuridine but not deoxycytidine nor uridine.
J, Kubilus, L D, Lee, H P, Baden
openaire +2 more sources
Substrate specificity of Escherichia coli thymidine phosphorylase
Biochemistry (Moscow), 2007Substrate specificity of Escherichia coli thymidine phosphorylase to thymidine derivatives modified at 5' -, 3' -, and 2' ,3' - positions of the sugar moiety was studied. Equilibrium and kinetic constants (K(m), K(I), k(cat)) of the phosphorolysis reaction have been determined for 20 thymidine analogs.
N G, Panova +9 more
openaire +2 more sources
International Journal of Oncology, 2003
Metastasis or progression of ovarian cancer cells is known to be due to the action of various angiogenic factors. We determined the expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor (TP/PD-ECGF) and vascular endothelial growth factor (VEGF) in cell lines established from 3 serous adenocarcinomas, 3 clear cell ...
Shizuka, Tsukagoshi +6 more
openaire +2 more sources
Metastasis or progression of ovarian cancer cells is known to be due to the action of various angiogenic factors. We determined the expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor (TP/PD-ECGF) and vascular endothelial growth factor (VEGF) in cell lines established from 3 serous adenocarcinomas, 3 clear cell ...
Shizuka, Tsukagoshi +6 more
openaire +2 more sources

